1,799
Views
0
CrossRef citations to date
0
Altmetric
Editorial

There is no single gold standard study design (RCTs are not the gold standard)

Pages 267-270 | Received 10 Jan 2023, Accepted 12 Apr 2023, Published online: 19 Apr 2023

References

  • Cartwright N. Are RCTs the gold standard? BioSocieties. 2007 Mar 01;2(1):11–20. DOI:10.1017/S1745855207005029
  • Ho PM, Peterson PN, Masoudi FA. Evaluating the evidence: is there a rigid hierarchy? Circulation. 2008 Oct 14;118(16):1675–1684. PubMed PMID: 18852378; eng. DOI:10.1161/circulationaha.107.721357
  • Hernán MA, Hernández-Díaz S, Robins JM. Randomized trials analyzed as observational studies. Ann Intern Med. 2013 Oct 15;159(8):560–562. PubMed PMID: 24018844; PubMed Central PMCID: PMCPMC3860874. eng. DOI:10.7326/0003-4819-159-8-201310150-00709
  • Cornfield J. Statistical relationships and proof in medicine (Edited by Ernest Rubin). Am Stat. 1954 Dec 5;8:19–21.
  • Ioannidis JPA. Contradicted and initially stronger effects in highly cited clinical research. JAMA. 2005;294(2):218–228.
  • Eikelboom JW, Connolly SJ, Bosch J, et al. Rivaroxaban with or without aspirin in stable cardiovascular disease. N Engl J Med. 2017 Oct 5;377(14):1319–1330. PubMed PMID: 28844192. DOI:10.1056/NEJMoa1709118
  • Moayyedi P, Eikelboom JW, Bosch J, et al. Safety of proton pump inhibitors based on a large, multi-year, randomized trial of patients receiving rivaroxaban or aspirin gastroenterology. Gastroenterology. 2019;157(3):682–691. PubMed PMID: 31152740; eng. DOI:10.1053/j.gastro.2019.05.056
  • Gerstman BB. Proton pump inhibitors and chronic kidney disease: reevaluating the evidence from a randomized controlled trial. Pharmacoepidemiol Drug Saf. 2021 Sep 9;30(1):4–8. PubMed PMID: 32909330; eng. DOI:10.1002/pds.5101
  • Krauss A. Why all randomised controlled trials produce biased results. Ann Med. 2018 Jun;50(4):312–322. PubMed PMID: 29616838; eng. DOI:10.1080/07853890.2018.1453233
  • Walach H, Loef M. Using a matrix-analytical approach to synthesizing evidence solved incompatibility problem in the hierarchy of evidence. J Clin Epidemiol. 2015 Nov;68(11):1251–1260. PubMed PMID: 26148834; eng. DOI:10.1016/j.jclinepi.2015.03.027
  • Miettinen OS. The need for randomization in the study of intended effects. Stat Med. 1983 Apr;2(2):267–271. PubMed PMID: 6648141. DOI:10.1002/sim.4780020222
  • Vandenbroucke JP. When are observational studies as credible as randomised trials? Lancet. 2004 May 22;363(9422):1728–1731.
  • Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med. 2000 Jun 22;342(25):1887–1892. PubMed PMID: 10861325; PubMed Central PMCID: PMCPMC1557642. eng. DOI:10.1056/nejm200006223422507
  • Papanikolaou PN, Christidi GD, Ioannidis JP. Comparison of evidence on harms of medical interventions in randomized and nonrandomized studies. CMAJ. 2006 Feb 28;174(5):635–641. PubMed PMID: 16505459; PubMed Central PMCID: PMCPMC1389826. eng. DOI:10.1503/cmaj.050873
  • Group for the Women’s Health Initiative Investigators W, WHI. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA. 2002 Jul 17;288(3):321–333. DOI:10.1001/jama.288.3.321
  • Stampfer M, Colditz G, Willett W, et al. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses’ health study. N Engl J Med. 1991 Sep 12;325(11):756–762.
  • Hernán MA, Alonso A, Logan R, et al. Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease. Epidemiology. 2008;19(6):766–779. PubMed PMID: PMC3731075. DOI:10.1097/EDE.0b013e3181875e61
  • Miettinen OS. The “case-control” study: valid selection of subjects. J Chron Dis. 1985;38(7):543–548. PubMed PMID: 4008595. DOI:10.1016/0021-9681(85)90039-6
  • Rothman KJ, Greenland S, Lash TL. Modern Epidemiology. Third ed. Baltimore: LWW; 2008.
  • Miettinen O. Estimability and estimation in case-referent studies. Am J Epidemiol. 1976;103(2):226–235. PubMed PMID: 0001251836. DOI:10.1093/oxfordjournals.aje.a112220
  • Onakpoya IJ, Heneghan CJ, Aronson JK. Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature. BMC Med. 2016 Feb 04;14(1):10. PubMed PMID: PMC4740994. DOI:10.1186/s12916-016-0553-2
  • Medical Research Council. Streptomycin treatment of pulmonary tuberculosis. Br Med J. 1948;2(4582):769–782. PubMed PMID: 18890300; eng. DOI:10.1136/bmj.2.4582.769
  • Rescher N. Oversimplification. Belgrade Philosophical Annual. 2014;27(27):85–91.
  • Savitz DA, Wellenius GA, Trikalinos TA. The problem with mechanistic risk of bias assessments in evidence synthesis of observational studies and a practical alternative: assessing the impact of specific sources of potential bias. Am J Epidemiol. 2019;188(9):1581–1585.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.